Standard therapy for high grade glioma is a topic that is evolving, timely, and relevant. In this book, some of the articles include: Use of language mapping to aid resection of eloquent gliomas; Clinical trials with immunotherapy; Clinical trials for small molecule inhibitors; and Nanotechnology potential applications for GBM therapy.